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The existence of disulfide crosslinks limits the number of possible folded structures a protein can assume. Thus localiza- 
tion of disulfide and thiol groups is a key to understanding the conformation and orientation of myelin proteolipid protein 
(PLP) in the myelin membrane. [~4C]Carboxamidomethylated PLP was fragmented with chymotrypsin, and the resulting 
mixture was partially separated by reversed-phase HPLC. Purified ~4C-labeled peptides and a disulfide containing peptide 
were characterized by amino acid analysis. These experiments showed that Cys-32 and Cys-34 are free thiols, and are 
presumably on the interior of the cell or within the membrane bilayer, and that Cys-200 and Cys-219 are joined by a 
disulfide bond, and are probably located on the extracellular face of the membrane. Sequence analysis experiments indi- 
cate that Cys-5, Cys-6 and Cys-9 are linked by disulfides, probably to other parts of the protein on the extracellular face 
of the membrane. 
Myelin proteolipid protein; Lipophilin; Polypeptide conformation; Disulfide bond; Membrane protein topology 
1. INTRODUCTION 
Myelin proteolipid protein (PLP), the major 
protein in central nervous system myelin [1], is 
thought o play an important role in the formation 
or maintenance of the multilamellar structure of 
myelin [2]. On the basis of amino acid sequence, 
two models for the folding of PLP in the myelin 
membrane have been proposed, one by Laursen et 
al. [3] and one by Stoffel et al. [4]. These two 
models share some common features, such as three 
transmembrane domains and two cis-membrane 
domains with intervening hydrophilic regions, but 
differ in regard to the orientation of some of the 
domains. PLP contains 14 cysteine residues, of 
which four can be alkylated with a variety of 
agents [5,6]; the remaining ten are presumed to be 
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involved in disulfide links. Because of the reducing 
environment of the cytoplasm, it is expected that 
the thior groups would be located on the 
cytoplasmic side and the disulfides on the ex- 
tracellular side [7]. The location of disulfide bonds 
puts significant constraints on the possible orienta- 
tions of the polypeptide chain within the mem- 
brane. For these reasons, we have attempted to 
locate the thiol groups and disulfide bonds in PLP 
in order to learn in more detail how PLP is 
organized in the myelin membrane bilayer. 
2. MATERIALS AND METHODS 
The myelin PLP was prepared from a washed chloroform- 
methanol extract of bovine brain white matter. Lipids were par- 
tially removed from the solutes by emulsification and cen- 
trifugation as described by Lees and Sakura [8]. This material 
is referred to as 'crude PLP' because it still contains lipids. 
2.1. Carboxamidomethylation of PLP 
Procedure A: a sample (200 mg) of crude PLP containing 
60 mg of protein was added to 20 ml of 50 mM Tris-HCI buffer 
(pH 8.2, containing 1°70 SDS, previously deaerated with N2). 
The protein was dissolved by sonication i  a bath-type sonicator 
for 20min. A quantity (20mg) of [~4C]iodoacetamide 
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(0.45/~Ci//zmol) was then added and allowed to react in the 
dark at room temperature. After 2 h, the reaction mixture was 
dialyzed in the dark against 20 mM Tris-HC1 (pH 8.0) for 2 
days, with renew of buffer twice a day. The slightly turbid solu- 
tion was used directly for proteolytic leavage. 
Procedure B: this procedure is identical to A except that the 
20 mg of [~4C]iodoacetamide was added to the reaction buffer 
before addition of 200 mg of the crude PLP sample. 
2.2. Carboxamidomethylation of PLP in myelin membrane 
Intact bovine myelin, prepared by the method of Norton [9], 
was labeled by a modification of the above procedure B. 
[14C]Iodoacetamide (20 rag, 0.45/~Ci//zmol) was dissolved in 
10 ml of Tris-HCl buffer (pH 8.2, previously deaerated with 
N2), and to it was added myelin membrane containing 50 mg 
protein. After 2 h in the dark at room temperature, the myelin 
was pelleted in an Eppendorf centrifuge. The pellets were 
suspended in 2 ml of chloroform/methanol (2:1), and un- 
dissolved material was removed by centrifugation. Ethyl acetate 
(1 ml) was added to the supernate to precipitate [14C]CAM- 
PLP. The precipitate was pelleted and 100/zl of Triton X-100 
was added, followed by 5 ml of 50 mM Tris-HCl (pH 8.0, con- 
taining 1 °70 SDS). The resulting solution was dialyzed as in pro- 
cedures A and B. 
2.3. Chymotryptic cleavage of [~C]CAM-PLP 
The cloudy diaiysates of [14C]CAM-PLP were digested with 
chymotrypsin (enzyme/protein ratio of 1:40) at 37°C. After 
6-8 h, chloroform/methanol (2: 1) was added, the mixture was 
shaken and the phases allowed to separate. The distribution of 
~4C in the upper and lower phases and in insoluble material at 
the interface was determined by liquid scintillation counting. 
2.4. Purification of peptides by reversed-phase HPLC 
The upper (aqueous) phase was lyophilized and the peptides 
were dissolved in 0.1070 trifluoroacetic a id to give a concentra- 
tion of about 1 mg/ml, and ll~b-200/~l was injected onto a 
C-18 reversed-phase HPLC column, which was then eluted with 
a linear gradient of 0.05% trifluoroacetic a id in acetonitrile in- 
to 0.05% acetonitrile. The eluate was monitored by absorbance 
at 214 and 254 nm, as well as by liquid scintillation counting 
and amino acid analysis of individual peaks. Some peptides 
were further purified by rechromatography using shallower gra- 
dients. 
2.5. Sequence analysis of PLP 
Procedure A: crude PLP (1 mg) was dissolved in 100/LI of 
98°70 formic acid, and 10/d of this solution was added to a 
polyvinylidine difluoride membrane disk which had been 
prewetted with methanol. The disk was allowed to air dry 
(10-20 min) and was then placed in 3 ml of 0.5 ml Tris-HCl 
(pH 8.2, 10070 methanol) and 27 mg of iodoacetamide. After 
2 h in the dark, the disk was removed, rinsed with water and 
allowed to dry. Sequencing ofthe protein was carried out on an 
Applied Biosystems model 470A gas-phase quencer quipped 
with a model 120A on-line phenylthiohydantoin analyzer. 
Procedure B: PLP was applied, as above, to a membrane disk 
which had been previously soaked for 4 h at 37°C in 3 ml of 
0.5 M Tris (pH 8.0, 10070 methanol) containing 9 mg of 
dithiothreitol. The membrane was then placed in an 
iodoacetamide solution and further treated as in procedure A. 
3. RESULTS AND DISCUSSION 
PLP  contains 14 Cys residues, 4 of which are 
believed to be in the reduced (thiol) state [5,6] and 
the remainder disulfides. In order to determine the 
oxidation state of individual residues, the thiol 
groups of PLP  were radiolabeled and an attempt 
was made to isolate both labeled and cystine- 
containing peptides. Because disulfide exchange is 
a distinct possibility in a protein that contains both 
thiols and disulfides, PLP  was alkylated with 
[14C]iodoacetamide using several procedures. The 
general approach was to label free thiol groups 
with [14C]iodoacetamide, cleave the protein with 
chymotrypsin,  and separate and identify the pep- 
tides. In  procedure A, no attempt was made to 
avoid exchange while the  protein was being 
solubilized before alkylation. In procedure B, 
iodoacetamide was added to the solubilizing buffer 
before addit ion of the protein, so that thiols would 
be blocked as the protein dissolves. Finally, PLP  
was alkylated in intact myelin, where the protein is 
presumably in its native state. 
The carboxamidomethylated proteins were then 
digested with chymotrypsin. The resulting peptides 
were part it ioned into ch loroform/methanol  and 
the distr ibution of label in the upper and lower 
phases and in insoluble interface material was 
determined. As shown in table 1, in all cases 
roughly half of the radioactivity appears in the up- 
per (aqueous) phase and half in the insoluble frac- 
t ion. Very little appears in the lower phase, which 
was not further analyzed. 
The upper phase peptides were then separated by 
reversed-phase HPLC;  alkylated thiol peptides 
were detected by liquid scinti l lation counting. 
Samples of eluted peptides were also subjected to 
amino acid analysis in order to identify those 
which contained cystine and CAM-cysteine. Using 
protein labeled by procedure A, we isolated three 
radioactive peptides, which accounted for 89°70 of 
the total radioactivity in the upper phase. The ma- 
jor ity of the radioactivity (75070) was in peaks 1 and 
2 (see below), while a minor  amount  (14070) was 
found in a fraction corresponding to peak 3a 
(residues 200-206). On the other hand, when 
either crude proteolipid or intact myelin was la- 
beled by procedure B, about 9007o f  the radioac- 
tivity could be accounted for by peaks 1 and 2; 3a 
was not observed. Furthermore,  in the latter two 
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Table 1 
Distribution of radioactivity after partition of [~4C]CAM-PLP 
chymotryptic peptides into chloroform/methanol (2:1) and 
water 
Phase Sample/alkylation procedure 
Crude PLP/  Crude PLP/ Myelin/ 
procedure A procedure B procedure B
Upper (aqueous) 51°7o 42% 42°70 
Interface 
(insoluble) 45070 52070 58% 
Lower (organic) 4% 6o70 0% 
experiments, a cystine-containing peptide (peak 3) 
was also isolated. When peak 3 was oxidized and 
rechromatographed, peptides corresponding to 
peaks 3a and 3b were isolated. Peptide composi- 
tions are given in table 2. 
peak 1 FCGCGHEALTGTEKL  (31-45) 
peak2 FCGCGHEALTGTEKL I  ETY  (31-49) 
peak 3 C A D A R MY (3a, 200-206) 
NAFPGKVCGS NL (3b, 212-223) 
These results indicate (i) that Cys-32 and Cys-34 
are present both in crude PLP and in myelin 
primarily as thiols and (ii) that residues Cys-200 
and Cys-219 are linked by a disulfide bond. The 
isolation of a small amount of peak 3a from 
material labeled by procedure A suggests that some 
thiol-disulfide xchange had taken place before 
alkylation. Since we can account for nearly all of 
the radiolabel in the upper phase, which represents 
about half of the total label, the remaining two 
CAM-Cys groups must be in the insoluble fraction 
(see table 1), which we have not yet been able to 
fractionate. 
PLP contains Cys residues near the 
NH2-terminus at positions 5, 6, 9, and 24. In order 
to ascertain their oxidation state, we first carbox- 
amidomethylated a sample of PLP and subjected 
it to Edman degradation i a gas-phase sequencer. 
Although interpretable data could be obtained on- 
ly through the first 15 or so cycles, no 
phenylthiohydantoin (PTH) corresponding to 
CAM-Cys was observed (fig.l). When another 
sample of PLP was first treated with dithiothreitol 
Table 2 
Amino acid analyses of derivatized thiol and disulfide peptides a 
Amino acid Peak 1 Peak 2 Peak 3a b Peak 3b b 
Cysteic acid 1.0 (1) 1.0 (1) 
CM-Cys 1.5 (2) c 1.4 (2) 
Asp 0.9 (1) 1.9 (2) 
Thr 1.5 (2) 2.4 (3) 
Ser 0.9 (1) 
Glu 1.7 (2) 2.5 (3) 
Pro 0.8 (1) 
Gly 3.3 (3) 3.1 (3) 2.1 (2) 
Ala 1.0 (1) 1.0 (1) 2.4 (2) 1.2 (1) 
Cys/2 
Val 0.9 (1) 
Met 0.5 (1) 
Ile 0.9 (1) 
Leu 2.3 (2) 2.2 (2) 1.0 (1) 
Tyr 0.8 (l) 0.8 (1) 
Phe 0.8 (1) 1.1 (1) 1.0 (1) 
His 1.3 (1) 1.2 (1) 
Lys 0.8 (1) 0.9 (1) 1.0 (1) 
Arg 0.6 (1) 
Sequence 31-45 31-49 200-206 212-223 
" Representative analyses of peptides obtained in several 
experiments. In a typical experiment, 30nmol of 
chymotryptic digest was separated by HPLC; individual 
peptides were obtained, after rechromatography, in 25-45% 
yield 
b Peptides obtained by performic acid oxidation of peak 3 
c Relative molar ratios; theoretical values are given in 
parentheses. Analyses are uncorrected for decomposition or
incomplete hydrolysis 
to reduce all disulfide bonds, and was then 
alkylated and subjected to sequence analysis, 
PTH-CAM-Cys was observed at positions 5, 6, 
and 9, as expected. 
This experiment shows that Cys-5, Cys-6 and 
Cys-9 are probably involved in disulfide linkages 
(assuming the unreduced sample did not become 
air-oxidized uring handling), and confirms earlier 
suggestions of Jolles et al. [10] that Cys-6 and 
Cys-9 are in the oxidized form. Furthermore, we 
had observed earlier [11] that the NH2-terminal 
tryptic peptide (Gly-1 to Arg-8) could only be 
isolated after cleavage of the disulfide bonds, in- 
dicating that Cys-5 and/or Cys-6 were crosslinked 
to other portions of the protein. Intuitively it can 
also be argued that these three residues must be in- 
volved in disulfide linkages. Since they are all in 
close proximity, they must all be on the same side 
of the membrane, either outside or inside, and 
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Fig. 1. (A) Plot of yields of PTH-CAM-Cys + PTH-Glu (which 
coelute on HPLC analysis) versus sequencing step. The lower 
curve, obtained by sequencing unreduced CAM-PLP, shows 
only PTH-GIu at position 4; the upper curve, obtained for 
reduced and carboxamidomethylated PLP, shows in addition to 
Glu-4, CAM-Cys at positions 5, 6 and 9. (B) Subtraction of the 
lower curve in A from the upper. This shows more clearly, 
despite the rising baseline, the yields of PTH-CAM-Cys in 
positions 5, 6 and 9. Although the yield in step 6 is significantly 
lower than in step 5, it is much more than can be accounted for 
by carryover from step 5. 
therefore all oxidized or all reduced, respectively 
[7]. Since there are 14 Cys residues in PLP, even 
numbers of Cys residues must be in the disulfide 
and thiol forms. If Cys-5, -6 and -9, as well as 
Cys-32 and -34, were thiols, then there would have 
to be a total of at least six thiols (an even number), 
rather than the observed four. 
In earlier studies [12], we isolated a fragment of 
PLP comprising residues 181-276 by cleavage at 
Trp-180 and Trp-211. The fact that this fragment 
consisted of two connected chains, showed that 
Cys residues 183, 200, 219 and 227 are intercon- 
nected by disulfide bonds, and that these Cys 
residues are not joined to other parts of the pro- 
tein. Since we have now shown that Cys-200 is 
linked to Cys-219, it follows that Cys-183 and 
Cys-227 are also linked. This argument assumes 
that Cys-183 and Cys-227 are not thiols, which is 
unlikely because topological considerations require 
them to be on the same face (presumably outer) of 
the membrane bilayer. 
We suspect that the remaining two cysteine 
residues are at positions 24 and 168, which are 
both in hydrophobic domains of the protein and 
are presumably embedded in the membrane bilayer 
where they could not easily form crosslinks. This 
leaves Cys residues 108, 138 and 140 to crosslink 
with Cys residues 5, 6 and 9, assuming that there 
are only four thiols and that the other ten are ac- 
tually involved in disulfide crosslinks. While this 
model agrees with our earlier one [2] in regard to 
the Cys-200 to Cys-219 and Cys-183 to Cys-227 
crosslinks, it is in better agreement with the model 
of Stoffel et al. [3], with respect to orientation of 
the extramembrane segments comprising residues 
36-58 and 91-150. Furthermore, the hydrophobic 
segment comprising residues 10-35, which we had 
proposed earlier [2] to be a cis-membrane domain, 
would have to be a trans-membrane in the new 
model. Yet even this revised model must be regard- 
ed as tentative, since recent observations [13] sug- 
gest that at least one thiol group may be acylated 
by a fatty acid and would not have been alkylated 
by iodoacetamide. Thus the total number of Cys 
residues in the reduced form may be greater than 
four and the number of disulfide crosslinks less 
than five. 
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